The increased content of the mitochondrial calcium uniporter (mitochondrial calcium uniporter, MCU) elevates calcium levels within the mitochondria, revealing Aβ’s adverse effects on mitochondrial function and suggesting that blocking MCU could emerge as a potential therapeutic strategy for AD (47). This evidence concerns the gene MCU and Alzheimer disease.